Reply from authors re: Camillo Porta. How to identify active novel agents in rare cancers and then make them available: A need for a paradigm shift. Eur Urol 2012;62:1020-1: Research in rare tumors: A need for a paradigm shift

Nizar M. Tannir; Peter Thall; Randall E. Millikan

doi:10.1016/j.eururo.2012.08.016

Reply from authors re: Camillo Porta. How to identify active novel agents in rare cancers and then make them available: A need for a paradigm shift. Eur Urol 2012;62:1020-1: Research in rare tumors: A need for a paradigm shift

Nizar M. Tannir, Peter Thall, Randall E. Millikan

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1022
Number of pages	1
Journal	European urology
Volume	62
Issue number	6
DOIs	https://doi.org/10.1016/j.eururo.2012.08.016
State	Published - Dec 2012

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2012.08.016

Cite this

Reply from authors re: Camillo Porta. How to identify active novel agents in rare cancers and then make them available: A need for a paradigm shift. Eur Urol 2012;62:1020-1: Research in rare tumors: A need for a paradigm shift. / Tannir, Nizar M.; Thall, Peter; Millikan, Randall E.
In: European urology, Vol. 62, No. 6, 12.2012, p. 1022.

Research output: Contribution to journal › Editorial › peer-review

@article{433e137ce1254466b662d3c66e5c4db1,

title = "Reply from authors re: Camillo Porta. How to identify active novel agents in rare cancers and then make them available: A need for a paradigm shift. Eur Urol 2012;62:1020-1: Research in rare tumors: A need for a paradigm shift",

author = "Tannir, {Nizar M.} and Peter Thall and Millikan, {Randall E.}",

year = "2012",

month = dec,

doi = "10.1016/j.eururo.2012.08.016",

language = "English (US)",

volume = "62",

pages = "1022",

journal = "European urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - Reply from authors re

T2 - Camillo Porta. How to identify active novel agents in rare cancers and then make them available: A need for a paradigm shift. Eur Urol 2012;62:1020-1: Research in rare tumors: A need for a paradigm shift

AU - Tannir, Nizar M.

AU - Thall, Peter

AU - Millikan, Randall E.

PY - 2012/12

Y1 - 2012/12

UR - http://www.scopus.com/inward/record.url?scp=84868581114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868581114&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2012.08.016

DO - 10.1016/j.eururo.2012.08.016

M3 - Editorial

AN - SCOPUS:84868581114

SN - 0302-2838

VL - 62

SP - 1022

JO - European urology

JF - European urology

IS - 6

ER -

Reply from authors re: Camillo Porta. How to identify active novel agents in rare cancers and then make them available: A need for a paradigm shift. Eur Urol 2012;62:1020-1: Research in rare tumors: A need for a paradigm shift

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this